OPKO Health Inc
OPK1.395USD
-0.005-0.36%
交易中 （美东）报价延迟15分钟
1.07B总市值
亏损市盈率 TTM
关于 OPKO Health Inc 公司
OPKO Health, Inc. 是一家跨国生物制药和诊断公司。该公司专注于利用其发现、开发和商业化专业知识以及新颖的专有技术。其部门包括制药和诊断。制药部门包括其在智利、墨西哥、爱尔兰、以色列和西班牙的制药业务、Rayaldee 产品销售及其制药研发。诊断部门主要包括即时诊断业务。其制药业务包括 Rayaldee，一种经美国食品药品管理局 (FDA) 批准的治疗患有三期或四期慢性肾病 (CKD) 和维生素 D 不足的成人继发性甲状旁腺功能亢进症 (SHPT) 的药物，以及 Somatrogon (hGH-CTP)，一种每周注射一次的人类生长激素注射剂。其 NGENLA (somatrogon-ghla) 是一种每周注射一次的人类生长激素类似物，适用于治疗三岁及以上的儿科患者。
OPKO Health Inc简介
公司代码OPK
公司名称OPKO Health Inc
上市日期Nov 02, 1995
CEODr. Tony F. Cruz, Ph.D.
员工数量2997
证券类型Ordinary Share
年结日Nov 02
公司地址- -
城市- -
上市交易所NASDAQ Global Select Consolidated
国家- -
邮编- -
电话- -
网址- -
公司代码OPK
上市日期Nov 02, 1995
CEODr. Tony F. Cruz, Ph.D.
OPKO Health Inc公司高管
名称
名称/职务
职务
持股
持股变动
Dr. Jane H. Hsiao, Ph.D.
Dr. Jane H. Hsiao, Ph.D.
Vice Chairman of the Board, Chief Technical Officer
Vice Chairman of the Board, Chief Technical Officer
33.13M
--
Mr. Steven D. (Steve) Rubin, Esq., J.D.
Mr. Steven D. (Steve) Rubin, Esq., J.D.
Executive Vice President - Administration, Director
Executive Vice President - Administration, Director
6.19M
-6.60%
Mr. John A. Paganelli
Mr. John A. Paganelli
Independent Director
Independent Director
393.51K
--
Mr. Adam E. Logal
Mr. Adam E. Logal
Chief Financial Officer, Senior Vice President, Chief Accounting Officer, Treasurer
Chief Financial Officer, Senior Vice President, Chief Accounting Officer, Treasurer
179.16K
-70.95%
Dr. Richard M. Krasno, Ph.D.
Dr. Richard M. Krasno, Ph.D.
Independent Director
Independent Director
103.33K
--
Dr. Elias A. Zerhouni, M.D.
Dr. Elias A. Zerhouni, M.D.
President, Vice Chairman of the Board
President, Vice Chairman of the Board
89.60K
-84.80%
Dr. Alice Lin-Tsing Yu, M.D., Ph.D.
Dr. Alice Lin-Tsing Yu, M.D., Ph.D.
Independent Director
Independent Director
66.49K
--
Mr. Richard C. (Rick) Pfenniger, Jr.
Mr. Richard C. (Rick) Pfenniger, Jr.
Independent Director
Independent Director
--
--
Dr. Tony F. Cruz, Ph.D.
Dr. Tony F. Cruz, Ph.D.
Chief Executive Officer, Transition Therapeutics, Inc
Chief Executive Officer, Transition Therapeutics, Inc
--
--
Dr. Roger J. Medel, M.D.
Dr. Roger J. Medel, M.D.
Independent Director
Independent Director
--
--
查看更多
名称
名称/职务
职务
持股
持股变动
Dr. Jane H. Hsiao, Ph.D.
Dr. Jane H. Hsiao, Ph.D.
Vice Chairman of the Board, Chief Technical Officer
Vice Chairman of the Board, Chief Technical Officer
33.13M
--
Mr. Steven D. (Steve) Rubin, Esq., J.D.
Mr. Steven D. (Steve) Rubin, Esq., J.D.
Executive Vice President - Administration, Director
Executive Vice President - Administration, Director
6.19M
-6.60%
Mr. John A. Paganelli
Mr. John A. Paganelli
Independent Director
Independent Director
393.51K
--
Mr. Adam E. Logal
Mr. Adam E. Logal
Chief Financial Officer, Senior Vice President, Chief Accounting Officer, Treasurer
Chief Financial Officer, Senior Vice President, Chief Accounting Officer, Treasurer
179.16K
-70.95%
Dr. Richard M. Krasno, Ph.D.
Dr. Richard M. Krasno, Ph.D.
Independent Director
Independent Director
103.33K
--
Dr. Elias A. Zerhouni, M.D.
Dr. Elias A. Zerhouni, M.D.
President, Vice Chairman of the Board
President, Vice Chairman of the Board
89.60K
-84.80%
收入明细
单位: USD更新时间: 10月6日 周一
单位: USD更新时间: 10月6日 周一
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
业务USD
名称
营收
占比
Health Insurers
58.48M
57.84%
Client Payers
23.17M
22.92%
Government Payers
17.10M
16.92%
Patients
2.35M
2.33%
地区USD
名称
营收
占比
United States
114.88M
73.26%
Chile
16.00M
15.83%
Ireland
11.74M
11.61%
Spain
6.72M
6.65%
Mexico
6.30M
6.23%
其他
-54.55M
-13.59%
业务
地区
业务USD
名称
营收
占比
Health Insurers
58.48M
57.84%
Client Payers
23.17M
22.92%
Government Payers
17.10M
16.92%
Patients
2.35M
2.33%
股东统计
更新时间: 8月16日 周六
更新时间: 8月16日 周六
持股股东
股东类型
持股股东
持股股东
占比
Frost Gamma Investments Trust
28.70%
Rubric Capital Management LP
6.23%
Holbrook (Bruce C)
5.26%
The Vanguard Group, Inc.
4.97%
Hsiao (Jane H)
4.32%
其他
50.53%
持股股东
持股股东
占比
Frost Gamma Investments Trust
28.70%
Rubric Capital Management LP
6.23%
Holbrook (Bruce C)
5.26%
The Vanguard Group, Inc.
4.97%
Hsiao (Jane H)
4.32%
其他
50.53%
股东类型
持股股东
占比
Corporation
37.85%
Investment Advisor
12.39%
Individual Investor
10.57%
Hedge Fund
7.62%
Investment Advisor/Hedge Fund
5.83%
Research Firm
1.05%
Bank and Trust
0.16%
Pension Fund
0.12%
Family Office
0.02%
其他
24.39%
机构持股
更新时间: 10月1日 周三
更新时间: 10月1日 周三
报告期
机构数
持股数
持股占比
持股变动
2025Q3
455
208.86M
27.21%
-55.45M
2025Q2
472
618.23M
77.88%
-578.48K
2025Q1
498
645.32M
88.41%
+25.74M
2024Q4
501
573.04M
84.80%
-7.63M
2024Q3
497
562.18M
81.01%
-12.00M
2024Q2
501
553.77M
79.70%
+8.59M
2024Q1
492
531.83M
76.52%
-21.84M
2023Q4
493
533.01M
69.65%
+31.42M
2023Q3
496
529.79M
69.24%
+23.70M
2023Q2
502
536.53M
70.13%
+25.42M
查看更多
股东持股明细
名称
持股数
占比
持股变动
变动比例
公告日期
Frost Gamma Investments Trust
220.16M
27.74%
+360.00K
+0.16%
Sep 30, 2025
Rubric Capital Management LP
47.79M
6.02%
-915.40K
-1.88%
Jun 30, 2025
Holbrook (Bruce C)
40.38M
5.09%
--
--
Feb 24, 2025
The Vanguard Group, Inc.
38.16M
4.81%
+8.74M
+29.70%
Jun 30, 2025
Hsiao (Jane H)
33.13M
4.17%
--
--
Apr 02, 2025
Frost Group, L.L.C.
30.13M
3.8%
--
--
Sep 30, 2025
BlackRock Institutional Trust Company, N.A.
28.22M
3.55%
+3.45M
+13.93%
Jun 30, 2025
GJN 2021 Trust
19.91M
2.51%
--
--
Feb 24, 2025
EGN 2021 Trust
19.91M
2.51%
--
--
Feb 24, 2025
Geode Capital Management, L.L.C.
10.42M
1.31%
+2.00M
+23.68%
Jun 30, 2025
查看更多
持股ETF
更新时间: 11月2日 周日
更新时间: 11月2日 周日
机构名称
占比
Invesco NASDAQ Future Gen 200 ETF
0.55%
SPDR S&P Health Care Services ETF
0.49%
VanEck Israel ETF
0.15%
Humankind US Stock ETF
0.11%
iShares U.S. Healthcare Providers ETF
0.11%
Goldman Sachs Innovate Equity ETF
0.08%
iShares MSCI USA Small-Cap Min Vol Factor ETF
0.06%
iShares Biotechnology ETF
0.05%
iShares Russell 2000 Value ETF
0.04%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
0.04%
查看更多
Invesco NASDAQ Future Gen 200 ETF
占比0.55%
SPDR S&P Health Care Services ETF
占比0.49%
VanEck Israel ETF
占比0.15%
Humankind US Stock ETF
占比0.11%
iShares U.S. Healthcare Providers ETF
占比0.11%
Goldman Sachs Innovate Equity ETF
占比0.08%
iShares MSCI USA Small-Cap Min Vol Factor ETF
占比0.06%
iShares Biotechnology ETF
占比0.05%
iShares Russell 2000 Value ETF
占比0.04%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
占比0.04%
分红派息
近5年累计派现
0.00
美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据
拆合股
公告日期
类型
比率
暂无数据
公告日期
类型
比率
暂无数据
